Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms, Unknown Primary × Drug Therapy × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 53 Breast Neoplasms 28 Lung Neoplasms 21 Neoplasm Metastasis 17 Pancreatic Neoplasms 16 Triple Negative Breast Neoplasms 15 Neoplasms 15 Colorectal Neoplasms 15 Head and Neck Neoplasms 13 Stomach Neoplasms 12 Esophageal Neoplasms 12 Squamous Cell Carcinoma of Head and Neck 11 Esophageal Squamous Cell Carcinoma 11 Rectal Neoplasms 10 Uterine Cervical Neoplasms 9 Small Cell Lung Carcinoma 9 Ovarian Neoplasms 9 Leukemia, Myeloid, Acute 7 Recurrence 6 Cholangiocarcinoma 6 Lymphoma 5 Fallopian Tube Neoplasms 5 Urinary Bladder Neoplasms 4 Sarcoma 4 Oropharyngeal Neoplasms 4 Mouth Neoplasms 4 Glioblastoma 4 Colonic Neoplasms 4 Adenocarcinoma Of Esophagus 4 Prostatic Neoplasms 3

Interventions

pembrolizumab 3 atezolizumab 2 Paclitaxel 2 Carboplatin 2 zenocutuzumab 1 veliparib 1 sintilimab 1 pertuzumab 1 pemigatinib 1 olaparib 1 ivosidenib 1 ipatasertib 1 entrectinib 1 cobimetinib 1 alectinib 1 Whole Genome Sequencing 1 Vemurafenib 1 Transurethral Resection of Prostate 1 Taxes 1 Specimen Handling 1 Sequence Analysis, RNA 1 Radiosurgery 1 Magnetic Resonance Spectroscopy 1 HhAntag691 1 Genetic Testing 1 Gemcitabine 1 Fluorodeoxyglucose F18 1 FAPI-46 1 Erlotinib Hydrochloride 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡